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Abstract
Background: Vitamin D deficiency is a common nutritional issue and dietary supplementation in the general
population, including pregnant women, is generally advised. Appropriately high levels of vitamin D are expected to
play a role in containing the glycemic and atherogenic profiles observed in pregnancy. However, the relation
between vitamin D status and the lipid metabolic profile in Saudi women, who are known to suffer from chronic
vitamin D deficiency and high incidence of obesity and type II DM, during the course of pregnancy is not known.
Methods: In this study, we analyzed the relation between serum vitamin D level and various serum metabolic
markers among Saudi women (n = 515) in their first trimester of pregnancy (11.2 ± 3.4 weeks). Coefficients of
Pearson correlation and Spearman rank correlation were calculated for Gaussian and non-Gaussian variables,
respectively. Serum vitamin D status was defined as (in nmol/L): deficient (<25), insufficient (25–50); sufficient
(50–75) and desirable (>75).
Results: Results indicated that vitamin D status was sufficient in only 3.5 % of the study participants and insufficient
and deficient in 26.2 % and 68.0 % of participants, respectively. Serum vitamin D values in the overall study
population correlated positively with serum levels of total cholesterol (R = 0.172; p < 0.01), triglycerides (R = 0.184;
p < 0.01) and corrected calcium (R = 0.141; p < 0.05). In the subgroup of vitamin D deficient subjects (n = 350), log
serum vitamin D values correlated with serum triglycerides (R = 0.23; p = 0.002) and cholesterol (R = 0.26; p = 0.001).
Conclusions: The positive correlations between serum vitamin D and the atherogenic factors such as total
cholesterol and triglycerides indicate a pro-atherogenic metabolic status in vitamin D deficient expectant mothers.
This may represent an adaptation to the high metabolic demands of pregnancy.
Keywords: 25(OH)D, Atherogenic, Cholesterol, Calcium, Hypovitaminosis D, Hypercholesterolemia,
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Background
Hypovitaminosis D in pregnant women is very common
and has important implications for the mother and life-
long health of the child, as it has been linked to maternal
and child infections, small-for-gestational age (SGA),
preterm delivery, preeclampsia, gestational diabetes mel-
litus (GDM), as well as DNA imprinting in the infant for
lifelong chronic diseases [1].
Vitamin D deficiency is a worldwide public health
problem in all age groups [2]. Globally, prevalence of
deficient and insufficient vitamin D status ranges from 5
to 84 % in pregnant women [3]. Countries in the
Middle-east, despite abundant sunshine, have reported
lower mean vitamin D levels than others, and higher de-
ficiencies in females than males have been attributed to
their conservative clothing and time spent indoors [4, 5].
Because of the possibility of balancing vitamin D status
through dietary supplementation, intense research is be-
ing pursued to gain an understanding of the various fac-
tors that affect vitamin D status and the effect of
vitamin D deficiency on normal health.
Accumulating evidence links vitamin D deficiency with
abnormal glucose and lipid metabolism, and epidemio-
logic studies have shown that women who develop
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GDM are more likely to be vitamin D deficient [6–8].
The three essential lipid indices (total cholesterol, tri-
glycerides and LDL cholesterol) increase during preg-
nancy and thus mimic the markers of metabolic
syndrome [9–11]. It was suggested that changes in
carbohydrate and lipid metabolic markers in pregnant
women may not reflect a pathologic condition but rather
indicate a necessary adaptation of the mother’s physi-
ology to balance the energy demands of the fetus and to
prepare the mother for delivery and lactation [12]. In
contrast, GDM was suggested to be a transient manifest-
ation of long-standing metabolic dysfunction [10].
Even though in vitro and in vivo animal studies show a
plethora of pathways regulated by Vitamin D, its role
during fetal development is not well understood. Obser-
vational evidence links low maternal vitamin D status
with an increased risk of non-bone health outcomes in
the mother [13], but the totality of the evidence for
health outcomes is oftentimes contradictory, lacks
mechanistic explanations, and is inconclusive [14]. In
the light of widespread occurrence of vitamin D defi-
ciency, regulatory agencies make recommendations for
significant dietary supplementation of vitamin D. How-
ever, uncertainty still exists regarding the optimum level
of vitamin D in pregnant women relative to both mater-
nal and fetal adverse health outcomes. In this respect,
vitamin D status data from different populations are ex-
pected to aid in finding optimum levels. This study was
performed to assess the vitamin D status in a population
of pregnant Saudi women and to analyze its relation with
various anthropometric and biochemical parameters, es-
pecially carbohydrate and lipid metabolic markers.
Methods
Subjects
A total of 515 hundred Saudi women in their 1st trimes-
ter of pregnancy (11.2 ± 2.75th week) were recruited from
King Fahad Medical City (n = 134), King Khalid Hospital
(288) and King Salman Hospital (93) in Riyadh, Saudi
Arabia. Only Saudi women ages 18–35 years with previ-
ous clinical data regarding maternal characteristics, gly-
cemic data and neonatal parameters were included in
the study. Women with previous history of diabetes mel-
litus (type I or II), malignancy, and history of chronic
kidney or liver disease were excluded. Written informed
consent was taken from each subject before study inclu-
sion. Approval was granted by the Ethics Committee of
the College of Science, King Saud University, Riyadh,
Kingdom of Saudi Arabia (KSA). Study subjects were
asked to complete a general questionnaire containing
demographic information, including past and present
medical history, and to return after fasting for more than
10 h for anthropometry and blood withdrawal.
Anthropometry and blood collection
Subjects were requested to visit their respective hospitals
between 8:00 and 9:00 h following an overnight fast
(>10 h) for anthropometry and blood withdrawal by the
nurse and physician on duty, respectively. Anthropom-
etry included height (rounded to the nearest 0.5 cm),
weight (rounded to the nearest 0.1 kg), waist and hip cir-
cumference (centimeters), and mean systolic and dia-
stolic blood pressure (mmHg, average of two readings).
Body mass index (BMI) was calculated as weight in kilo-
grams divided by height in square meters. Fasting blood
samples were collected and transferred immediately to a
non-heparinized tube for centrifugation. Collected
serum was then transferred to pre-labeled plain tubes,
stored on ice, and delivered to the Biomarkers Research
Program (BRP) in King Saud University, Riyadh, KSA,
for immediate storage at −20 °C.
Sample analyses
Fasting glucose, lipid profile, calcium, and phosphorous
were measured using a chemical analyzer (Konelab, Es-
poo, Finland). Serum 25(OH)D was measured with a
Roche Elecsys modular analytics Cobas e411 using an
electrochemiluminescence immunoassay (Roche Diag-
nostics, GmbH, Mannheim, Germany) and commercially
available IDS kits (IDS Ltd, Boldon Colliery, Tyne &
Wear, UK). Variation for the 25(OH)D ELISA were
5.3 % and 4.6 %, respectively, with 100 % cross-reactivity
to 25(OH)D3 and 75 % cross-reactivity to 25(OH)D2. It
should be noted that the BRP laboratory is a participat-
ing entity in the Vitamin D External Quality Assessment
Scheme (DEQAS), and Quality Assurance (QA) stan-
dards are maintained by ISO 9000 and 17025. The QA
department audits the BRP laboratory at regular inter-
vals. Serum levels (in mmol/L) of glucose <6.1, total
cholesterol <5.0, triglycerides <1.7 and calcium 2.25-2.75
were considered normal/desirable.
Data analyses
Data were analyzed using SPSS (version 16.5 Chi-
cago, IL, USA). Mean and standard deviations were
used to represent the data for the Gaussian variables,
while median and interquartile range were used to
report non-normal variables. Furthermore, frequen-
cies and percentages (%) were reported for the cat-
egorical data. Normality assumption was assessed
using the Kolmogorov-Smirnov test. Pearson correl-
ation coefficients were calculated for both Gaussian
and log-transformed non-Gaussian variables. Multi-
nomial logistic regression was conducted to assess
the relationship between select variables and vitamin
D status. P-value <0.05 was considered statistically
significant.
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Results
Prevalence of vitamin D deficiency
515 normal, healthy women in their 1st trimester of preg-
nancy were recruited in this prospective study aiming to
determine the effect of vitamin D status on the develop-
ment or not of GDM, during the progression of preg-
nancy. Blood samples were obtained from these women at
the 11.20 (2.75th) week of pregnancy and were analyzed
for serum 25(OH)D and various other biochemical param-
eters. Results from the analysis of anthropometric and bio-
chemical parameters of these women are shown in
Table 1. For the whole study population (n = 515), the
means (SD) (in mmol/L) of serum glucose [4.79 (0.76)],
total cholesterol [4.70 (1.03)], triglycerides [1.37 (0.59)],
calcium [2.27 (0.17)] and corrected calcium [2.24 (0.16)]
were within the normal/desirable ranges.
Thirty two (or 6.4 %) of the recruited women had fast-
ing blood glucose level in excess of 6.1 mmol/L. This
sub-group of subjects had a mean vitamin D level of
24.42 ± 15.4 nmol/L which was not different from the
mean of the whole study group (data not shown). How-
ever, because of the small number of women with abnor-
mal levels of glucose and due to the prevalence of
vitamin D deficiency in the vast majority of subjects,
additional analyses were performed on data from the
whole group of recruits. “Hypercholesterolemia” (total
cholesterol >5.0 mmol/L) and “hypertriglyceridemia”
(triglycerides >1.7 mmol/L) were detected among 32.9 %
and 25.8 % of the subjects, respectively.
To gain a better understanding of the relationship be-
tween vitamin D and obesity, age, gestational age and
parity, multinomial logistic regression analysis was per-
formed for the select variables with vitamin D status (in-
sufficient and deficient) as dependent variable. Results
are shown in Table 2. None of the above variables
showed any significant association with vitamin D status.
However, among the hypertriglyceridemic and hypercho-
lesterolemic women, the latter was significantly associ-
ated with insufficient vitamin D status [OR: 13.61 (95 %
CI 1.10-168.28)].
Table 1 Anthropometric and clinical characteristics and their association with log serum vitamin D level in pregnant women
Parameters Mean ± SD Log Vitamin D Correlation Coefficient (R) p-value
N 515
Age (years) 28.71 (6.07) 0.100* 0.02
BMI (kg/m2) 28.47 (6.22) −0.002 0.96
Age of menarche (years) 12.95 (1.63) 0.047 0.60
Age at 1st pregnancy (years) 23.57 (4.49) 0.076 0.42
Gestation week 11.20 (2.75) −0.065 0.30
Waist (cm) 87.54 (12.23) −0.021 0.82
Hips (cm) 108.01 (12.34) 0.092 0.31
Waist-hip ratio 0.81 (0.07) −0.124 0.17
Systolic 110.03 (11.56) 0.083 0.11
Diastolic 64.81 (8.72) 0.021 0.68
Gravida# 2.00 (3.00) 0.027 0.61
Parity# 1.00 (2.00) 0.008 0.90
Ca (mmol/L) 2.27 (0.17) −0.107* 0.02
Total cholesterol (mmol/L) 4.70 (1.03) 0.172** 0.01
Glucose (mmol/L) 4.79 (0.76) 0.090 0.08
Phosphate-inorganic (mmol/L) 1.13 (0.25) 0.090 0.88
HDL-Cholesterol (mmol/L) 1.14 (0.25) 0.017 0.81
Triglycerides (mmol/L)# 1.24 (0.78) 0.184** 0.00
Corrected Ca (mmol/L) 2.24 (0.16) 0.141* 0.03
Vitamin D (nmol/L)# 19.13 (15.08) —————— ——————
Vitamin D - deficient 350 (68 %) —————— ——————
Vitamin D - insufficient 135 (26.2 %) —————— ——————
Vitamin D - sufficient 18 (3.5 %) —————— ——————
Vitamin D - desirable 12 (2.3 %) —————— ——————
Note: Column1: data presented as mean ± standard deviation; # denotes non-Gaussian and data is presented as median (IQR); categorical data presented as
frequency and percentages; p-value significant at <0.05. Column 2: data presented as coefficient (R);* p < 0.05; ** p < 0.01
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Based on the previously described clinical categories of
vitamin D status [15–18], the subjects were classified
into four groups as following: deficient (<25 nmol/L), in-
sufficient (25–50 nmol/L); sufficient (50–75 nmol/L)
and desirable (75 < nmol/L). Results indicated that 68,
26.2, 3.5 and 2.3% of the women had deficient, insuffi-
cient, sufficient, and desirable levels of vitamin D, re-
spectively (Table 1). The overall study population had a
mean serum vitamin D level of 23.36 (15.74) nmol/L.
Serum vitamin D correlational analysis
Correlation coefficients of various anthropometric and
biochemical parameters with log serum vitamin D
values, determined as mentioned in Methods, are shown
in Table 1. Significant positive associations were detected
for serum levels of total cholesterol (R = 0.172; p = 0.01),
triglycerides (R = 0.184; p < 0.01) and corrected calcium
(R = 0.141; p = 0.03). Besides these, significant associa-
tions were also found between serum vitamin D and age
in years (R = 0.100; p = 0.02). A negative correlation,
which however was not statistically significant, was de-
tected for uncorrected calcium (R = −0.107). No add-
itional correlations were found. Furthermore, multiple
regression analyses performed using log serum vitamin
D status against all metabolic parameters included in the
study did not show any significant associations (results
not shown).
In the vitamin D deficient sub-group of women
[25(OH)D <25 nmol/L; n = 350], log vitamin D values
were positively correlated with serum total cholesterol
(R = 0.263; p = 0.001) (Fig. 1) and triglycerides (R = 0.234;
p = 0.002) (Fig. 2).
The mean serum vitamin D levels in the sub-groups of
hypertriglyceridemic and hypercholesterolemic subjects
were 31.41 (17.29) [control: 26.41 (17.29)] and 30.59
(18.38) [control: 26.82 (17.97)] nmol/L, respectively, and
were significantly different (p = 0.013 and p = 0.021, re-
spectively, from respective controls.
Discussion
In this study, we assessed the serum vitamin D status of
515 normal, healthy Saudi women in their first trimester
of pregnancy, and analyzed its association with several
GDM-related anthropometric and serum biochemical
markers. Vitamin D deficiency was highly prevalent, with
only 3.5 % of the women having sufficient and an
Table 2 Multinomial logistic regression analysis of vitamin D status versus select parameters
Parameters Sufficient & Desired
Vitamin D (≥50 nmol/L)
Insufficient (between 25–50 nmol/L) Deficient (<25 nmol/L)
OR (95 % CI) p-value OR (95 % CI) p-value
Hypertriglyceridemia (>1.7 mmol/L) 1.0 0.30 (0.04-1.97) 0.209 0.49 (0.08-2.94) 0.437
Hypercholesterolemia (>5.0 mmol/L 1.0 13.61 (1.10-168.28) 0.042 10.14 (0.86-118.90) 0.065
Obesity (>30 kg/m2) 1.0 0.93 (0.15-5.69) 0.938 0.77 (0.14-4.31) 0.762
Gestational Age (≤12 weeks) 1.0 0.23 (0.03-1.53) 0.128 0.24 (0.04-1.49) 0.127
Age (>40 years) 1.0 0.19 (0.01-2.54) 0.210 0.29 (0.03-2.85) 0.289
Multipara (>1) 1.0 0.51 (0.05-5.67) 0.586 0.58 (0.06-6.12) 0.653
Note: p-value significant at <0.05; p-value significant at <0.01
Fig. 1 Association between serum log vitamin D and cholesterol concentrations in vitamin D deficient women. In the vitamin D deficient
sub-group of women [25(OH)D <25 nmol/L; n = 350], the relation between serum levels of log 25(OH)D/vitamin D and total cholesterol was
determined by Pearson correlation coefficient analysis. Results are presented as a scatter plot
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additional 2.5 % of the women having desirable levels of
vitamin D, while the rest (94.2 %) were either insufficient
or deficient. Thirty two of these women had abnormally
high level of fasting glucose. Hypercholesterolemia and
hypertriglyceridemia were detected among 25.8 % and
32.9 % of the subjects, respectively. Serum vitamin D
level was positively correlated to total cholesterol, tri-
glycerides and corrected calcium in our study subjects,
while the mean serum levels of these same parameters
were within their normal ranges for the total population.
Vitamin D level was even more strongly correlated to
total cholesterol and triglycerides in the vitamin D-
deficient sub-group of women. However, regression ana-
lysis indicated a modest risk of hypercholesterolemia
among women with insufficient vitamin D. We speculate
that the unexpected positive correlations between vita-
min D and lipids may be the outcome of a combination
of deficient vitamin D status with the high metabolic de-
mands of pregnancy.
Recent research at the cellular level indicates pleio-
tropic roles for vitamin D, while clinical trials involving
high doses have not been associated with toxicity.
Hence, intense research efforts are being made to deter-
mine the normal/deficiency levels with a view to
normalize vitamin D status, via dietary supplementation,
in persons with chronic diseases and in children, preg-
nant women and adults for possible prevention of the
same. East African populations with traditional lifestyles
having lifelong, year-round exposure to tropical sunlight
have a mean serum vitamin D concentration of
115 nmol/L, independently of age, sex or BMI [19]. The
pregnant adults of these populations had higher serum
vitamin D than their non-pregnant counterparts. Most
investigators agree that serum vitamin D should be
higher than 50 nmol/L, but some recommend even
higher serum levels. Various factors, such as race and
geographical location, affect vitamin D levels and risk
groups for vitamin D deficiency include pregnant
women, children, older persons, the institutionalized and
non-western immigrants. Vitamin D deficiency in the
Middle-East adults is highly prevalent [20]. The Institute
of Medicine (IOM) recently revised the recommended
dietary allowances (RDA) for vitamin D (above 50 nmol/
L) to sustain normal bone density, calcium absorption,
and to minimize risk of osteomalacia and rickets. Results
from many clinical trials that show benefits and/or no
adversity with doses of vitamin D that raise serum vita-
min D to levels beyond 75 nmol/L support the desirabil-
ity of having serum vitamin D levels greater than
75 nmol/L [18].
Several recent studies have reported widespread preva-
lence of hypovitaminosis D among adolescent girls and
pregnant and post-natal women in Saudi Arabia and
around the world [21, 22]. Even though hypovitaminosis
D (<50 nmoles/L) was highly prevalent (96.3 % of the
subjects), inter-trimester variations were not observed in
a cross-sectional study involving 541 women in India
[23]. Vitamin D deficiency in an earlier study on healthy
Saudi pre-and postmenopausal women was related to
obesity, poor exposure to sunlight, and poor dietary vita-
min D supplementation [24]. However, in another study,
a cohort of 139 healthy young Saudi Arabian blood do-
nors (87 males and 52 females) had vitamin D defi-
ciency, despite the fact that >65 % of the participants
had adequate exposure to sunlight, while > 90 % reported
adequate intake of dairy products [25].
6.4 % of the pregnant women of this study had higher
than expected serum glucose level, indicating several
candidates for possible gestational diabetes. According
to a 2014 analysis by the US Centers for Disease Control
and Prevention, the prevalence of GDM was as high as
9.2 %; further, while the severity of GDM increased with
Fig. 2 Association between serum log vitamin D and triglyceride concentration in vitamin D deficient women. In the vitamin D deficient
sub-group of women [25(OH)D <25 nmol/L; n = 350], the relation between serum levels of log 25(OH)D/vitamin D and total triglycerides was
determined by Pearson correlation coefficient analysis. Results are presented as a scatter plot
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the progression of pregnancy, with the whole-body insu-
lin sensitivity reduced 45 % to 70 % below non-pregnant
values during the third trimester of pregnancy [26]. The
oral glucose tolerance test (OGTT) planned among
these women in the latter part of their pregnancy is ex-
pected to provide us a better understanding of the rela-
tion between vitamin D and GDM.
Free/ionic calcium in all the subjects or in the vitamin
D-deficient sub-group of pregnant women was signifi-
cantly related to vitamin D. The mechanistic basis of
ionic calcium homeostasis is still not completely estab-
lished. However, the roles of the important individual
players of calcium homeostasis aid in hypothesizing that
serum levels of free/ionized calcium may be reciprocally
regulated by parathyroid hormone (PTH) and 1, 25-
dihydroxyvitamin D, with the former one serving to in-
crease serum level of calcium and the latter to suppress
it. PTH causes net bone loss (resorption) and increases
blood calcium levels by stimulating osteoclasts. High
levels of vitamin D have been shown to inhibit PTH syn-
thesis in vitro and in vivo [27, 28]. Vitamin D deficiency
is implicated in reduced serum albumin concentrations
[29]. Hence, serum ionic/free calcium, which is non-
albumin bound calcium, is expected to be higher in vita-
min D deficiency conditions.
Plasma vitamin D levels are elevated in normal early
pregnancy and continue to increase throughout preg-
nancy, while they remain elevated postpartum in lactat-
ing women [30]. The elevated levels probably represent
a physiologic response to increased calcium require-
ments. Calcitonin is a major positive regulator for the
expression of renal 25-hydroxyvitamin D3-1-alpha-hydrox-
ylase gene in normocalcemic rats. Calcitonin selectively
stimulates 25-hydroxyvitamin D3-1-alpha-hydroxylase in
the proximal convoluted tubule of rat kidney [31]. Plasma-
calcitonin levels were significantly higher throughout nor-
mal pregnancy and lactation than in normal non-pregnant
women [32]. Thus, more calcitonin circulates at times of
physiologically increased calcium needs.
The increases in calcitonin and vitamin D may be im-
portant in the transfer of maternal calcium to the fetus
and in the prevention and recovery of maternal bone
loss. Pregnancy and lactation place unique metabolic de-
mands. Increased insulin, as well as higher level of glu-
cose, are observed in gestational diabetes mellitus,
possibly as a result of the progressively increasing insulin
resistance in pregnancy. Similarly, hypercalcemia and in-
creased vitamin D may occur together in pregnancy.
Several studies have shown an “atherogenic” metabolic
bias during normal pregnancy, whose intensity increased
with progression of pregnancy. Increases in the levels of
triglycerides and unchanged HDL-cholesterol levels were
associated with GDM [11, 33]. Exaggerated hypertriglyc-
eridemia, particularly in the VLDL and HDL fractions,
was a feature of GDM [34]. In VLDL, core lipids (TG +
cholesterol) increased over normal gestation and were
greater in GDM then women with no GDM.
Although inconclusive, vitamin D is generally consid-
ered anti-atherogenic, as several observational studies
and recent meta-analyses in humans showed an inverse
correlation between circulating vitamin D and poor car-
diovascular outcomes [35–37]. Besides, vitamin D acti-
vates cholesterol efflux from macrophages, a critical
component in atherosclerotic plaque regression [38], in-
hibits cholesterol synthesis by inhibiting HMG CoA reduc-
tase [39] and suppresses lipolysis in adipocytes stimulated
by the β-adrenergic receptor pathway through increasing
intracellular calcium levels [40, 41].
Despite all these purported anti-atherogenic actions of
vitamin D, our results indicate significant positive corre-
lations between serum 25(OH)D levels and the athero-
genic factors total cholesterol and triglycerides. A
plausible explanation for the positive correlation in the
pregnant woman may be a normal response to preg-
nancy, as tissues such as liver, muscle and fat may be-
come more responsive to placental hormones; this is
supported by the finding that progesterone increased
cholesterol synthesis, which was inhibited by various sta-
tins [42]. Further, the hyperglycemic and hyper-
insulinemic and condition of GDM may facilitate syn-
thesis of cholesterol by their direct influence on liver
and adipose tissues [43]. Serum triglycerides in pregnant
women are increased 1.5 to 2-fold above non-pregnant
concentrations by the third trimester and remain high
around the clock [44], and this is attributed mainly to a
combination hyperinsulinemia promoting triglyceride
synthesis in the liver, increased food intake resulting in
increased appearance of chylomicrons from the gut and
reduced activity of lipoprotein lipase in adipose tissue,
resulting in decreased clearance of triglycerides from the
circulation [45]. Thus, besides influencing carbohydrate
metabolism, insulin and placental hormones, such as hu-
man placental lactogen, secreted during the course of
pregnancy stimulate, either directly or indirectly some of
the adaptations of maternal lipid metabolism. The major
tissues affected by human placental lactogen are the
liver, skeletal and heart muscles and adipose tissues.
Also, a modest positive relation was found between in-
sufficient vitamin D status and hypercholesterolemia
through regression analysis. The study subjects consisted
of women in their 1st trimester of pregnancy; future
follow-up studies on these same women during the suc-
cessive trimesters were planned and these might provide
better clues in understanding the relation between vita-
min D deficiency and pregnancy-induced atherogenic
lipid metabolic markers. A quantitative relation between
serum vitamin D and atherogenic markers during preg-
nancy is expected to help reveal the role of vitamin D in
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pregnant and perinatal women and provide useful clues
regarding the optimal level of vitamin D supplementa-
tion in pregnancy.
Conclusions
Vitamin D is an endogenous hormone with pleiotropic
roles in normal physiology. Under normal conditions,
vitamin D exerts anti-atherogenic, anti-diabetic, anti-
osteoporotic activities. In this study, women in the first
trimester of pregnancy had high prevalence of vitamin D
deficiency; surprisingly, however, serum vitamin D in
these subjects correlated positively with serum levels of
triglycerides, cholesterol and corrected calcium. We be-
lieve that this abnormal association may represent adap-
tation to the high metabolic demands of pregnancy and
future studies during later trimesters planned for these
women are expected to provide better explanation.
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